Progressive Parkinsonism in <scp> <i>PPP2R5D</i> </scp> ‐Related Neurodevelopmental Disorder

PPP2R5D-related neurodevelopmental disorder (Houge-Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease-modifying therapies currently in clinical trials. We describe a 33-year-old woman with this condition who developed progressive mixed-tremor parkinsonism in early adulthood. Dopamine transporter imaging confirmed presynaptic nigrostriatal dysfunction. Whole-genome sequencing identified the recurrent de novo pathogenic missense variant PPP2R5D p.Glu198Lys. The clinical triad of macrocephaly, intellectual disability, and early-onset parkinsonism is specific for this condition and should prompt targeted genetic evaluation even in adults with a longstanding diagnosis of a neurodevelopmental disorder.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2026-07-17
DOI
https://doi.org/10.1002/acn3.70492
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Progressive Parkinsonism in PPP2R5D ‐Related Neurodevelopmental Disorder

Kathryn Yang, Beril Ay, Darius Ebrahimi‐Fakhari, Katerina Bernardi et al.
Annals of Clinical and Translational Neurology
Genomics and Rare Diseases
article

Progressive Parkinsonism in PPP2R5D ‐Related Neurodevelopmental Disorder

Kathryn Yang, Beril Ay, Darius Ebrahimi‐Fakhari, Katerina Bernardi, Shabbir Hussain I. Merchant, Joshua Rong, Enrique Gonzalez Saez‐Diez
article en

Abstract

PPP2R5D-related neurodevelopmental disorder (Houge-Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease-modifying therapies currently in clinical trials. We describe a 33-year-old woman with this condition who developed progressive mixed-tremor parkinsonism in early adulthood. Dopamine transporter imaging confirmed presynaptic nigrostriatal dysfunction. Whole-genome sequencing identified the recurrent de novo pathogenic missense variant PPP2R5D p.Glu198Lys. The clinical triad of macrocephaly, intellectual disability, and early-onset parkinsonism is specific for this condition and should prompt targeted genetic evaluation even in adults with a longstanding diagnosis of a neurodevelopmental disorder.

Annals of Clinical and Translational Neurology
Boston Children's Hospital (US), Beth Israel Deaconess Medical Center (US), Heidelberg University (DE), University Hospital Heidelberg (DE)
National Institute of Neurological Disorders and Stroke
Openalex Percentile: Top 8%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Progressive Parkinsonism in <scp> <i>PPP2R5D</i> </scp> ‐Related Neurodevelopmental Disorder — Kathryn Yang, Beril Ay, et al. · Annals of Clinical and Translational Neurology (2026) | TGRS Research Map | TGRS